REGN5837 clinical trials

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

This study is testing two new drugs, Odronextamab and REGN5837, for people with aggressive B-cell Non-Hodgkin Lymphoma that has come back or not responded to previous treatments. It aims to find a safe dose and see how well they work together.